Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 11;17(1):e77284.
doi: 10.7759/cureus.77284. eCollection 2025 Jan.

Comparison of 3Mixtatin and Mineral Trioxide Aggregate in Primary Teeth Pulpotomy: A Systematic Review

V Lalitha Priya  1 , Kavitha Ramar  1
Affiliations
Review

Comparison of 3Mixtatin and Mineral Trioxide Aggregate in Primary Teeth Pulpotomy: A Systematic Review

V Lalitha Priya et al. Cureus. .

Abstract

The aim of this systematic review was to evaluate the clinical and radiographic success rates of primary teeth pulpotomy using 3Mixtatin compared to mineral trioxide aggregate (MTA). A comprehensive literature search identified relevant studies, which were screened for inclusion, with the risk of bias assessed using Cochrane collaboration tools. Data on success rates, follow-up periods, and methodological quality were extracted, and the protocol was registered in PROSPERO (ID: CRD42024562155). Among the four analyzed studies, Jamali et al. reported 24-month clinical success rates of 90.5%, 88.1%, and 78.9% for 3Mixtatin, MTA, and formocresol, respectively. Chak et al. observed a 95.7% clinical success rate for 3Mixtatin over 12 months, with no data on MTA, while Mushtaq et al. found comparable success rates for both 3Mixtatin and MTA. Reddy et al. reported clinical and radiographic success rates of 91.7% and 81.7% for formocresol, 100% and 91.7% for MTA, and 95% and 85% for 3Mixtatin at 6 and 12 months, respectively. Radiographically, 3Mixtatin demonstrated slightly better short-term outcomes than MTA. These findings suggest that both 3Mixtatin and MTA are effective for pulpotomy in primary dentition, with 3Mixtatin offering potential advantages due to its antibiotic and statin properties that may enhance healing and antibacterial effects. Additional studies involving larger and more diverse populations are required to confirm these findings.

Keywords: 3mixtatin; calcium silicate materials; mineral trioxide aggregate; pediatric dentistry; primary teeth pulpotomy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. PRISMA flow diagram of the literature research process and results
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
See this image and copyright information in PMC

References

    1. Treatment outcomes of pulpotomy in primary teeth with irreversible pulpitis: a systematic review and meta-analysis. Lin GS, Chin YJ, Choong RS, Wafa SW, Dziaruddin N, Baharin F, Ismail AF. Children (Basel) 2024;11:574. - PMC - PubMed
    1. Factors that influence the outcome of pulpotomy in permanent teeth. Duncan HF, El-Karim I, Dummer PM, Whitworth J, Nagendrababu V. Int Endod J. 2023;56 Suppl 2:62–81. - PubMed
    1. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis. Taha NA, Abdelkhader SZ. Int Endod J. 2018;51:819–828. - PubMed
    1. Vital pulp therapy in primary dentition: Pulpotomy - a 100-year challenge. Igna A. Children (Basel) 2021;8:841. - PMC - PubMed
    1. A histopathological comparison of pulpal response to chitra-cpc and formocresol used as pulpotomy agents in primary teeth: a clinical trial. Ratnakumari N, Thomas B. Int J Clin Pediatr Dent. 2012;5:6–13. - PMC - PubMed

LinkOut - more resources